| European Case Law Identifier: | ECLI:EP:BA:2012:T094909.20121017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 17 October 2012 | ||||||||
| Case number: | T 0949/09 | ||||||||
| Application number: | 99936809.5 | ||||||||
| IPC class: | C12Q 1/68 B01J 19/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Arrayed biomolecules and their use in sequencing | ||||||||
| Applicant name: | Illumina Cambridge Limited | ||||||||
| Opponent name: | Helicos Biosciences Corporation | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Termination of appeal proceedings after lapse of patent in the absence of a request for continuation by the appellant/opponent within the period prescribed | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t090949eu1.html
Date retrieved: 17 May 2021
8 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
EPC Implementing Rules
XR.84 EPC Continuation of the opposition proceedings by the European Patent Office of its own motion